15 Participants Needed

Thought-Controlled Bionic Arm for Arm Amputees

(iSens Trial)

DJ
MS
Overseen ByMelissa S Schmitt
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: VA Office of Research and Development
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The purpose of this research is to gather information on the safety and effectiveness of an implanted wireless sensory enabled highly intuitive controlled prosthetic device.

Will I have to stop taking my current medications?

The trial protocol does not specify whether you need to stop taking your current medications. However, if you use any active medical devices that are necessary for your health, you may not be eligible to participate.

What data supports the effectiveness of the treatment iSens, iSense optical scanner, and Implantable Myoelectric Sensors (IMES) for arm amputees?

Research shows that implantable myoelectric sensors can help amputees control prosthetic limbs more naturally by detecting muscle signals directly, allowing for better movement control. Additionally, studies indicate that providing feedback to the brain about limb movement can improve control of prosthetic hands, suggesting that these technologies can enhance the effectiveness of bionic arms.12345

Is the thought-controlled bionic arm safe for human use?

There is interest in implantable interfaces for prostheses, but long-term risks are a concern. Durability, comfort, and improved functional abilities are important factors for users.678910

How is the iSens treatment different from other treatments for arm amputees?

The iSens treatment is unique because it uses implantable sensors placed directly in the muscles to control a bionic arm, allowing for more intuitive and simultaneous control of multiple movements compared to traditional surface-based systems that often control movements sequentially.211121314

Research Team

DJ

Dustin J. Tyler, PhD

Principal Investigator

Louis Stokes VA Medical Center, Cleveland, OH

Eligibility Criteria

This trial is for adults over 21 who have had an upper limb amputation at least 6 months ago and are using or prescribed a myoelectric prosthesis. They must be mentally fit to participate, as confirmed by a psychologist, and have healthy nerves in the affected limb. People with poor wound healing, infections, pregnancy, inability to speak English, arthritis near the implant area or those needing MRI scans can't join.

Inclusion Criteria

I am 21 years old or older.
A psychologist has confirmed I'm mentally fit for the study.
It has been over 6 months since my amputation.
See 4 more

Exclusion Criteria

I have arthritis near where my implant is located.
I have long-lasting open sores on my skin.
Inability to speak English
See 9 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Surgical Implantation

Surgical implant of cuff electrodes on residual nerves and muscle recording electrodes in muscles, connected to an implanted stimulator

1 week

Treatment

Participants use the iSens system or their own prosthesis for 3 months

3 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

9 months

Treatment Details

Interventions

  • iSens
Trial OverviewThe study tests 'iSens', an implanted wireless device that aims to enhance control of prosthetic limbs through improved sensory feedback. It's designed for people with arm amputations to see if it's safe and effective compared to current prosthetic devices.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: iSensExperimental Treatment1 Intervention
3 months trial with the iSens system
Group II: State of the Art ProsthesisActive Control1 Intervention
3 months trial with their own prosthesis.

iSens is already approved in United States for the following indications:

🇺🇸
Approved in United States as iSense optical scanner for:
  • Residual limb volume measurement
🇺🇸
Approved in United States as Implantable Myoelectric Sensors (IMES) for:
  • Control of externally powered prosthetics

Find a Clinic Near You

Who Is Running the Clinical Trial?

VA Office of Research and Development

Lead Sponsor

Trials
1,691
Recruited
3,759,000+

United States Department of Defense

Collaborator

Trials
940
Recruited
339,000+

Defense Advanced Research Projects Agency

Collaborator

Trials
19
Recruited
78,900+

Findings from Research

The study involved 18 participants (9 unilateral amputees and 9 controls) and used advanced techniques like functional MRI to show that brain activation patterns are similar when both groups mentally simulate foot movement, indicating that the brain retains its ability to command movement even after amputation.
These findings suggest that brain activation can potentially be harnessed to control artificial limbs, offering promising implications for rehabilitation strategies for amputees.
A preliminary functional brain study on amputees.da Paz, AC., Braga, LW., Downs, JH.[2022]
The development of an implantable myoelectric sensor allows for more precise control of prosthetic hands and wrists by detecting muscle signals directly at the source, potentially enabling independent control of multiple movements.
In initial tests, a subject was able to intuitively and simultaneously control two degrees of freedom in a prosthetic hand, demonstrating the system's effectiveness and paving the way for future human clinical trials.
Development of an implantable myoelectric sensor for advanced prosthesis control.Merrill, DR., Lockhart, J., Troyk, PR., et al.[2021]
Bionic limbs provide a crucial interface between biological tissue and electronic devices, enhancing motor control and sensory feedback for amputees, which can lead to better reintegration into society and improved embodiment of the prosthetic limb.
There are three main types of bionic limb interfacing: targeted muscular reinnervation (TMR), direct muscle interfacing, and direct nerve interfacing, each offering unique advantages such as improved sensation and controllability, while the surgical implantation process aims to minimize nerve damage.
The current state of bionic limbs from the surgeon's viewpoint.Bumbaširević, M., Lesic, A., Palibrk, T., et al.[2020]

References

A preliminary functional brain study on amputees. [2022]
Development of an implantable myoelectric sensor for advanced prosthesis control. [2021]
The current state of bionic limbs from the surgeon's viewpoint. [2020]
Control Capabilities of Myoelectric Robotic Prostheses by Hand Amputees: A Scientific Research and Market Overview. [2020]
Illusory movement perception improves motor control for prosthetic hands. [2020]
The Ewing Amputation: The First Human Implementation of the Agonist-Antagonist Myoneural Interface. [2023]
A fully implanted intramuscular bipolar myoelectric signal recording electrode. [2023]
The Reality of Myoelectric Prostheses: Understanding What Makes These Devices Difficult for Some Users to Control. [2020]
Patient perspectives on benefits and risks of implantable interfaces for upper limb prostheses: a national survey. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
A third arm - Design of a bypass prosthesis enabling incorporation. [2018]
11.United Statespubmed.ncbi.nlm.nih.gov
Compensating for delays in brain-machine interfaces by decoding intended future movement. [2020]
12.United Statespubmed.ncbi.nlm.nih.gov
Technical Details of the Implantable Myoelectric Sensor (IMES) System for Multifunction Prosthesis Control. [2021]
13.United Statespubmed.ncbi.nlm.nih.gov
Upper extremity myoelectric prosthetics. [2005]
14.United Statespubmed.ncbi.nlm.nih.gov
The artificial substitution of missing hands with myoelectrical prostheses. [2005]